High-quality human biospecimens collected prospectively through our global network of IRB-approved clinical partners and healthcare institutions. Our prospective collection programs are designed to support study-specific requirements with standardized protocols, regulatory compliance, and end-to-end operational coordination.
We provide customized biospecimen collection services with strict quality control, detailed clinical metadata, and flexible study designs to support clinical research, biomarker discovery, translational research, and diagnostic development.
Our prospective collections enable researchers to obtain precisely defined biospecimens based on specific study criteria such as disease indication, patient demographics, treatment status, and collection timelines. Working closely with clinical sites, we design and implement tailored collection protocols to ensure consistency, sample integrity, and regulatory compliance throughout the process.
From single time-point collections to complex longitudinal studies, we support a wide range of biospecimen types including blood, plasma, serum, PBMCs, tissues, urine, and other biological matrices. Each sample is collected, processed, and stored under validated SOPs with temperature-controlled logistics, comprehensive documentation, and full chain-of-custody traceability.
Our experienced project management team coordinates site selection, patient recruitment, ethics approvals, kit preparation, and logistics to ensure seamless execution and reliable delivery of high-quality biospecimens for research programs.
● Fully Custom Collection Protocols designed around your study needs.
● Healthy, diseased, and rare patient cohorts across diverse clinical sites.
● Wide range of collection types: blood, biofluids, tissues, swabs, PBMCs, slides, digital images, and more.
● Longitudinal & time-course sampling with customizable visit schedules.
● Matched multi-matrix sample sets (e.g., tissue + blood + swabs + slides).
● Onsite or centralized processing including isolation, aliquoting, stabilization, freezing, and extraction.
● Global reach with domestic and international clinical partnerships.
● IRB-approved workflows ensuring ethical collection and full compliance.
● IRB/Ethics Committee approval for all prospective collections.
● Certified clinical sites following GCP, HIPAA, CLIA, and CAP-aligned practices.
● Standardized SOPs for collection, processing, and storage.
● Chain-of-custody traceability from donor to delivery.
● Temperature-controlled logistics with validated cold-chain shipping.
● Rigorous QC/QS including sample integrity checks, processing documentation, and site-level audits.
Every prospective collection can include customizable, IRB-approved metadata, such as:
●Demographics: age, sex, ethnicity, BMI, lifestyle factors.
● Clinical history: diagnosis, staging, onset dates, comorbidities.
● Treatment information: medications, therapeutic response, washout periods.
● Laboratory values: CBC/CMP, biomarkers, infectious disease results.
● Visit-level data: timestamps, fasting status, vitals, symptoms.
● Sample-level metadata: processing time, storage conditions, stabilization method, aliquot counts, freeze/thaw cycles.
